Patent · US Active

Triazine compounds as PI3 kinase and mTOR inhibitors

US8859542B2 · kind B2 · utility

5Cited by
1References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 23, 2014
Grant dateOct 14, 2014
Priority date—
Expiry dateApr 23, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D498/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of formula Iwherein:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.